In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Close this windowThis post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Rollout and onboarding
From 3 April 2023, the Moderna Bivalent BA.4-5 vaccine will be included for use as a booster in eligible people aged 12 years+ in the COVID-19 Vaccination Program. Sites will have received an onboarding letter containing information about next steps to commence vaccinating with the Moderna Bivalent BA.4-5 vaccine.
New packaging
The Moderna Bivalent BA.4-5 vaccine comes as a single dose pre-filled syringe. The pre-filled syringe packaging is significantly larger than multidose vials and will take up much more space in the vaccine fridge, so immunisation providers must consider this when ordering vaccines.
Mandatory training
The Moderna Bivalent (BA.4-5) 12 years+ (PFS) vaccine training modules will be available from 22 March 2023 on the COVID-19 Vaccination Training Program website.
All immunisation providers administering the Moderna Bivalent BA.4-5 vaccine must complete the relevant training module prior to a administering the vaccine.
The existing Moderna Bivalent 18 years+ (Blue/Green) has been renamed in CVAS to Moderna Bivalent (BA.1) 18 years+ (Blue/Green) to clearly differentiate it from the new BA.4-5 formulation. The existing Moderna Bivalent (BA.1) 18 years+ (Blue/Green) is only for use as a booster dose in adults 18 years and over and comes in a multidose vial.
Moderna Bivalent BA.1 allocations will be reduced to 50 doses per fortnight for all sites from 11 March 2023 to align with the opening of orders for Moderna Bivalent BA.4-5.
AstraZeneca vaccine has been offboarded from the COVID-19 Vaccination Program and can no longer be ordered from CVAS. All AstraZeneca vaccine doses will expire on 20 March 2023. Check AstraZeneca vaccines remaining in fridge on 21 March (the day after expiry) and report any wastage in CVAS:
NCIRS Influenza & COVID-19 update 2023
About: Annual influenza webinar to learn more about the updated recommendations for COVID-19 and influenza vaccination in 2023.
When: Thursday | 16 March 2023 | 12.00 – 1:00pm (AEDT)
Lunch and Learn: Milestone checks at scheduled childhood vaccination appointments
About: Please join us for a lunch and learn presentation on milestone checks – making the most of scheduled childhood vaccination appointments. Learn how to appropriately provide a milestone check to children attending your practice for scheduled vaccination.
When: Tuesday | 28 March 2023 | 12:30 – 1:30 pm
CESPHN Annual Immunisation Update
About: Latest updates on the COVID-19 vaccination program, NSW Influenza Vaccination Program and more. Agenda TBC
When: Tuesday | 4 April 2023 | 7:00 – 8:30 pm (AEDT)
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
EOI for Randwick Medicare Urgent Care Clinic The Central and Eastern Sydney PHN (CESPHN) is calling for Expressions of Interest (EOI) from general practices, or Aboriginal Community Controlled Health Services that may be willing and able to operate a Medicare Urgent Care Clinic (UCC) in the Randwick LGA. Medicare UCCs…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. CESPHN board member and lawyer Larissa Cook, who recently attended the Canterbury Head to Health launch, shared this: 1. What did you eat yesterday? My husband brought me coffee and toast in bed (which…
